DRAFLAZINE, L-
Molecular Formula:
C30H33Cl2F2N5O2
InChI: InChI=1/C30H33Cl2F2N5O2/c31-25-15-23(35)16-26(32)29(25)37-28(40)18-39-14-13-38(17-27(39)30(36)41)12-2-1-3-24(19-4-8-21(33)9-5-19)20-6-10-22(34)11-7-20/h4-11,15-16,24,27H,1-3,12-14,17-18,35H2,(H2,36,41)(H,37,40)/f/h37H,36H2
InChIKey: InChIKey=IWMYIWLIESDFRZ-ZYXXTMJVCI
SMILES: C1CN(C(CN1CCCCC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C(=O)N)CC(=O)NC4=C(C=C(C=C4Cl)N)Cl
Names:
DRAFLAZINE, L-
1-[(4-amino-2,6-dichloro-phenyl)carbamoylmethyl]-4-[5,5-bis(4-fluorophenyl)pentyl]piperazine-2-carboxamide
138681-29-5
Registries:
PubChem CID 60849
PubChem ID 197088
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|